/Investors

SARAS CAPITAL

Venture capitalActively deploying

Canterbury · 1 people tracked

Find your way into SARAS CAPITAL

1,344 people in our graph share verified history with the SARAS CAPITAL team — schools, employers, funds. One of them is your warm intro.

Lewis Pinaultunlockedknows Nadav Rosenberg · together at Birkbeck, University of London (overlapped)
knows the team · via Birkbeck, University of London
×10knows the team · via Entrepreneur First
✨ Fox Verdict
Sign up to see your fit

Fund manager profile

SARAS CAPITAL is a venture fund manager based in Canterbury. SEC filings show 2 venture funds on record, most recently SARAS CAPITAL II LP filed December 2025.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Canterbury
Founded
2024
Last 12 months
6 investments
Tracked investments
14
Acquisitions
1

Team · 1 people

from public directories
Nadav Rosenberg· General Partnerin

What they invest in

from 14 of 14 portfolio companies

AI & Machine Learning ×10Biotech ×7Enterprise Software ×4Healthtech ×4Deep Tech ×3Medical Devices ×3SaaS ×3Data & Infrastructure ×2

HQs:United States×6United Kingdom×4Germany×1France×1

Investments · 14 tracked

founders shown can be your intro path

By year:2026 · 42025 · 42022 · 12021 · 110 dated

Kyronkyron.bioMay 2025✓ verified

Kyron.bio is a biotechnology company focused on developing therapeutic drugs, with an in-house R&D and laboratory operation.

BiotechDeep TechHealthtechParis, FR

Emilia McLaughlin(Cofounder)in

Co-investorsEntrepreneur FirstHCVCVerve VenturesGSV Ventures

NanoSyrinx Seednanosyrinx.com✓ verified

NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development.

AI & Machine LearningBiotechDeep TechMedical DevicesCoventry, GB

Dr. Joe Healey(Founder)Dr. Nick Waterfield(Founder)Dr. Alexia Hapeshi(Founder)Joe(Founder and former CEO)Nick(Scientific Advisor and Co-founder)Thomas J. Farrell(CEO)

Co-investorsIQ CapitalOctopus VenturesFuture Planet CapitalM Ventures

Biographicagraphica.bioinJan 2026

Graphica applies foundational AI models to precision plant breeding, genetics and molecular biology, building plants and biological products.

AgTechAI & Machine LearningBiotechLondon, GB

Cecy Price(CEO)inDominic Hall(CTO)in

Co-investorsEntrepreneur FirstFaberFaber Capital SCR SANucleus CapitalSie VenturesSuperSeed+4 more

Cellbytecellbyte.cominNov 2025 · $2.8M

Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE

Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel

Co-investorsFrontline VenturesPace VenturesY CombinatorSpringboard Health Angels

Convergerunconverge.comin𝕏Jan 2026 · $25M

Converge is an AI-native growth platform for direct-to-consumer brands that automates media buying, attribution analysis, and reporting through agentic AI.

AdTechAI & Machine LearningDirect to ConsumerE-commerceEnterprise SoftwareSaaSNew York City, US

Jan-Henrik Lambrechts(Founder)inJerome Billiet(Founder)inThomas Holvoet(Founder)in

Co-investorsEntourage VenturesY CombinatorBessemer Venture PartnersTLV PartnersVintage Investment Partners

Convergeconvergeins.cominJan 2026 · $25M

Converge is an insurtech company that underwrites cyber risk insurance, distributing coverage to broker-partners across the U.S. through a capacity partnership with QBE.

AI & Machine LearningCybersecurityFintechInsurTech

Steven Petrevski(Founder)inTom Kang(Chief Executive Officer)Howie Altman(Chief Technology Officer)in

Co-investorsForgePoint CapitalBessemer Venture PartnersTLV PartnersVintage Investment Partners

Converge Bioconverge-bio.cominJan 2026 · $25M

Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies.

AI & Machine LearningBiotechDeep TechClaymont, US

Dov Gertz(CEO & Co-Founder)inOded Kalev(CTO & Co-Founder)inIddo Weiner(CSO & Co-Founder)in

BoardShahar Tzafrir(Director)inAndrew Hedin(Director)in

Co-investorsBessemer Venture PartnersTLV PartnersVintage Investment Partners

Delfadelfa.aiAug 2025

Delfa provides an AI-driven platform for clinical trial patient recruitment, centralizing calls, notes, and updates while automating repetitive tasks for clinical research site teams.

AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB

Tom Farrand(CEO)inGustav Bredell(CTO)in

Co-investorsAir Street CapitalEntrepreneur FirstTranspose Platform Management

Eden Bioeden.bioNov 2022

Eden Bio develops machine-learning technology for genetic engineering and protein yield optimization across food, pharmaceutical, and biofuel industries.

AI & Machine LearningBiotech

Co-investorsSynBioVenUnruly CapitalSemantic Ventures

Flexcitonflexciton.comin𝕏Oct 2021

Flexciton develops AI-driven production planning and scheduling software for semiconductor fabs, using mathematical optimization to improve throughput, tool utilization, and on-time delivery.

Advanced ManufacturingAI & Machine LearningSemiconductorsLondon, GB

Jamie Potter(CEO)inDionysios Xenos(CTO)in

Co-investorsBackedEntrepreneur FirstChalfen VenturesNadav Rosenberg

Parseparse.comacquired by Meta

Parse provides cloud-based backend infrastructure and tools for developers to build applications across mobile, desktop, and embedded platforms, including data storage, push notifications, and usage analytics.

Developer ToolsEnterprise SoftwareSan Francisco, US

Kevin Lacker(Founder/CTO)in

Co-investorsDCVC (Data Collective)Y Combinator

Parseparse.botin

Parse provides an API platform that converts web actions and data retrieval from any website into single API calls without running a browser.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Alex Forman(Founder)in

Co-investorsY Combinator

Parseparse.lyin𝕏

Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.

Data & InfrastructureMarketing TechMedia & Entertainment

Co-investorsHaatchHorizon Technology FinanceJanus Henderson InvestorsSahsen VenturesSoleus Capital

Valink Therapeuticsvalinktx.cominOct 2025

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Arne Scheu(Founder)inIrsyad Khairil(Founder)in

Co-investorsHoxton VenturesLongeVCMetaplanetOxonian VenturesP53 InvestSynBioVen+4 more

Exits · 1

1 acquisitions

Parseacq. by Meta

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has SARAS CAPITAL made?
SARAS CAPITAL has 14 tracked investments, 1 of which have exited, including 8 dated in the last 24 months.
Where is SARAS CAPITAL located?
SARAS CAPITAL is headquartered in Canterbury.